U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07332247) titled 'PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC' on Dec. 24, 2025.
Brief Summary: This phase II randomized trial evaluates PD-1 inhibitor plus chemotherapy followed by immediate versus selective re-irradiation in locally advanced recurrent nasopharyngeal carcinoma. The study aims to determine whether sequential radiotherapy provides additional survival benefit beyond systemic immunochemotherapy.
Study Start Date: Jan. 01
Study Type: INTERVENTIONAL
Condition:
Nasopharangeal Cancer
Recurrent Nasopharynx Carcinoma
Intervention:
RADIATION: Selective re-irrad...